Sr. Director - Clinical Operations Program Leader (COPL)

Who is BlueRock?

BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson's disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.

What Are We Doing?

Our foundational science harnesses the ability to create and then direct the differentiation of universal pluripotent stem cells into authentic, functional cells that can be used as allogeneic cellular therapies to treat a broad array of diseases. We can also further engineer these cells, enabling them to produce enzymes, antibodies, and other proteins for additional therapeutic benefit.

We are passionate about delivering on the promise of cellular and gene therapy, shaping the future of cellular medicine, and delivering new therapies to millions of patients with treatment options.

We are seeking individuals who are collaborative, thrive in a fun and dynamic culture, and are steadfast in the commitment to advance cutting-edge cellular therapies to impact patients' lives.

Our Pipeline Vision :

Neurology :

BlueRock is advancing an innovative pipeline of cell therapies in neurology, focused on addressing the urgent needs of patients with neurodegenerative and neurological disorders. Our lead neurology program,

bemdaneprocel (DA01) , is a first-in-class, allogeneic cell therapy designed to replace lost dopaminergic neurons in patients with Parkinson's disease. This program is currently in phase 3 development with the exPDite-2 clinical trial ongoing in the US, Canada, and Australia. Additional neurology pipeline assets, including

DA02 and

MG0X , are in research phase targeting other high-impact neurological conditions.Our goal is to restore function, slow or halt disease progression, and transform the standard of care for patients with debilitating neurological diseases.

Ophthalmology :

BlueRock is expanding its innovative cell therapy portfolio into ophthalmology, with a focus on addressing unmet medical needs in retinal diseases. Our lead ophthalmology program,

OpCT001 , is a first-in-class, allogeneic cell therapy candidate designed to replace lost or damaged retinal pigment epithelial (RPE) cells in patients with advanced retinal disorders, such as geographic atrophy secondary to age-related macular degeneration (AMD). OpCT001 leverages our CELL+GENE platform to generate authentic, functional RPE cells from pluripotent stem cells, with the goal of restoring vision and halting disease progression.

BlueRock is committed to scientific excellence, operational rigor, and the highest standards of ethics and compliance. The company fosters an inclusive, collaborative environment where innovation, diversity, and patient-centricity drive every decision.

About the Role : The

Clinical Operations Program Leader (COPL) is responsible for the strategic planning, execution, and oversight of BlueRock's clinical development programs across multiple studies and geographies. This leadership role ensures alignment with corporate goals, regulatory requirements, and timelines, while fostering cross-functional collaboration and operational excellence in the advancement of next-generation cell therapies.

Responsibilities :

• Clinical Program Leadership :
• Provide strategic and operational leadership for one or more complex clinical programs, ensuring successful execution from early-phase through pivotal trials.
• Develop and maintain clinical program planning and execution timelines. Model a data driven mindset to planning and oversight of studies.
• Maintain a comprehensive overview of program status, proactively communicating progress, risks, and mitigation strategies to stakeholders.
• Drive operational planning, including feasibility assessments, country / site selection, and resource allocation.
• Clinical Trial Operations :
• Oversee all aspects of clinical trial management, including protocol development, study start-up, enrollment, monitoring, data collection, and close-out.
• Ensure adherence to timelines, budgets, and quality standards across all studies within the program.
• Collaborate with internal teams (Clinical Development, Regulatory, Data Management, Safety, Quality) and external partners (CROs, vendors, academic collaborators) to ensure seamless trial execution.
• Implement and track key performance indicators (KPIs) and operational dashboards to monitor program health.
• Vendor & Site Management :
• Lead the selection, qualification, and management of CROs and vendors, ensuring high-quality deliverables and contract compliance.
• Serve as the primary point of escalation for operational issues at the program level.
• Build and maintain strong relationships with clinical trial sites, investigators, and key opinion leaders.
• Compliance & Process Improvement :
• Ensure all clinical activities are conducted in accordance with ICH-GCP, FDA, EMA, and other applicable regulatory guidelines.
• Support audit readiness and lead risk mitigation initiatives.
• Contribute to the advancement of department and organizational initiatives.
• Team Leadership & Development :
• Provide line management, coaching, and mentorship to clinical operations staff.
• Foster a culture of accountability, innovation, and professional growth.
• Innovation :
• Champion the development and implementation of novel clinical operations activities and methods in cell therapy.

Minimum Requirements :

Working Environment :

#LI-AL1

BlueRock Therapeutics Company Culture Highlights

Winner of Boston Business Journal's Best Places to Work (Mid-size Company) 2023

Winner of Comparably's Award for Best Company for Diversity 2022

Winner of Comparably's Award for Best Company for Women 2022

Winner of Comparably's Award for Best CEO 2022

BlueRock Therapeutics is ranked in the top 5% of companies for Overall Culture on Comparably.

Engineering Department is ranked in the top 5% of companies for Overall Culture on Comparably.

Check us out on Comparably : https : / / www.comparably.com / companies / bluerock-therapeutics

Follow us on Linkedin : https : / / www.linkedin.com / company / bluerocktx /

Equal Opportunity Workplace :

At BlueRock, we welcome and support differences and diversity and we are proud to be an equal opportunity workplace. Please let us know if you require disability-related accommodation or other grounds protected by human rights legislation during the recruitment process so that we can work with you to meet your needs.